Psychedelic stocks: focus on their cash
Investing Experts
Management Changes and Strategic Focus at MindMed
This chapter explores the recent management changes at MindMed and their positive effects on the company's growth and public perception. It highlights the transition under a new CEO with FDA expertise and the strategic focus on attracting biotech investors, bolstered by encouraging phase 2B trial outcomes.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
